Hainan Huluwa Pharmaceutical Grop Co Ltd (605199) Stock Price & News

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	175.05M	218.12M	146.14M	94.74M
Cost of goods sold	109.36M	249.53M	109.42M	91.85M
Cost of revenue	109.36M	249.53M	109.42M	91.85M
Research and development expenses	946.68K	73.54M	6.36M	4.58M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	66.76M	122.38M	44.56M	50.47M
Operating expense	39.98M	246.00M	48.45M	52.66M
Total operating expenses	149.33M	495.53M	157.87M	144.51M
Operating income	25.72M	-277.41M	-11.74M	-49.77M
Other non operating income	1.26M	-1.31M	-41.63K	-27.99M
EBT including unusual items	-11.40M	-265.45M	-28.10M	-84.16M
EBT excluding unusual items	17.79M	-289.30M	-20.47M	-69.08M
Income tax expense	666.12K	11.33M	310.34K	-604.95K
Effective tax rate	-5.84%	-4.27%	-1.10%	0.72%
Other operating expenses	-30.88M	35.66M	-3.28M	-1.57M
Net income	-13.62M	-276.16M	-28.96M	-84.43M
Net profit margin	-7.78%	-126.61%	-19.82%	-89.12%
Earnings per share	-	-	-	-
Interest and investment income	79.70K	133.90K	201.59K	8.89M
Interest expense	-9.27M	-10.71M	-8.89M	-201.59K
Net interest expenses	-9.19M	-10.57M	-8.69M	8.69M
Depreciation and amortization charges	-	-	-	-
EBITDA	44.06M	-253.42M	12.26M	-24.54M
Gain or loss from assets sale	-323.74K	53.83K	-	-

AI content may include mistakes. Learn more

Finance